Podcast: US FDA’s End-Of Year Approval ‘Rush’ And Other Criticisms: Fact Or Fiction?
FDA has been criticized in recent months for approving drugs too quickly, based on insufficient evidence. The agency’s oncology chief Richard Pazdur fights back.
FDA has been criticized in recent months for approving drugs too quickly, based on insufficient evidence. The agency’s oncology chief Richard Pazdur fights back.